Table of Content


1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Insulin Pen Market


6. Market Share

6.1 By Products
6.2 By Disease Types
6.3 By Distribution Channels
6.4 By Country


7. Product

7.1 Disposable Insulin Pen
7.2 Reusable Insulin Pen


8. Disease Types

8.1 Type 1 Diabetes
8.2 Type 2 Diabetes


9. Distribution Channels

9.1 Hospital Pharmacies
9.2 Retail Pharmacies
9.3 E-commerce


10. Countries

10.1 North America

10.1.1 United States
10.1.2 Canada

10.2 Europe

10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherlands
10.2.8 Turkey

10.3 Asia Pacific

10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Thailand
10.3.6 Malaysia
10.3.7 Indonesia
10.3.8 Australia
10.3.9 New Zealand

10.4 Latin America

10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina

10.5 Middle East & Africa

10.5.1 Saudi Arabia
10.5.2 United Arab Emirates
10.5.3 South Africa


11. Porters Five Forces

11.1 Bargaining Power of Buyer
11.2 Bargaining Power of Supplier
11.3 Threat of New Entrants
11.4 Rivalry among Existing Competitors
11.5 Threat of Substitute Products


12. SWOT Analysis

12.1 Strengths
12.2 Weaknesses
12.3 Opportunities
12.4 Threats


13. Reimbursement Policies


14. Company Analysis

14.1 B. Braun Melsungen AG

14.1.1 Overview
14.1.2 Key Persons
14.1.3 Product Analysis
14.1.4 Recent Development
14.1.5 Revenue

14.2 Eli Lilly and Company

14.2.1 Overview
14.2.2 Key Persons
14.2.3 Product Analysis
14.2.4 Recent Development
14.2.5 Revenue

14.3 Becton, Dickinson(BD)

14.3.1 Overview
14.3.2 Key Persons
14.3.3 Product Analysis
14.3.4 Recent Development
14.3.5 Revenue

14.4 Novo Nordisk A/S

14.4.1 Overview
14.4.2 Key Persons
14.4.3 Product Analysis
14.4.4 Recent Development
14.4.5 Revenue

14.5 Ypsomed AG

14.5.1 Overview
14.5.2 Key Persons
14.5.3 Product Analysis
14.5.4 Recent Development
14.5.5 Revenue

14.6 Terumo Corporation

14.6.1 Overview
14.6.2 Key Persons
14.6.3 Product Analysis
14.6.4 Recent Development
14.6.5 Revenue

14.7 Sanofi

14.7.1 Overview
14.7.2 Key Persons
14.7.3 Product Analysis
14.7.4 Recent Development
14.7.5 Revenue

14.8 Julphar

14.8.1 Overview
14.8.2 Key Persons
14.8.3 Product Analysis
14.8.4 Recent Development
14.8.5 Revenue